Gore, Lia

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

Teachey, D. T., Rheingold, S. R., Maude, S. L., Zugmaier, G., Barrett, D. M., Seif, A. E., Nichols, K. E., Suppa, E. K., Kalos, M., Berg, R. A., et al. (2013) · Blood

Autoimmune and Inflammatory Disorders ResearchCAR-T cell therapy research

Cited by 613

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

Gore, L., Rothenberg, M. L., O'Bryant, C. L., Schultz, M. K., Sandler, A. B., Coffin, D., McCoy, C., Schott, A., Scholz, C., & Eckhardt, S. G. (2008) · Clinical Cancer Research

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation

Cited by 171

Entinostat for treatment of solid tumors and hematologic malignancies

Knipstein, J., & Gore, L. (2011) · Expert Opinion on Investigational Drugs

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation

Cited by 110

Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma

Geoerger, B., Bergeron, C., Gore, L., Sender, L., Dunkel, I. J., Herzog, C., Brochez, L., Cruz, O., Nysom, K., Berghorn, E., et al. (2017) · European Journal of Cancer

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 98

ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma

Batlevi, C. L., Kasamon, Y., Bociek, R. G., Lee, P., Gore, L., Copeland, A., Sorensen, R., Ordentlich, P., Cruickshank, S., Kunkel, L., et al. (2016) · Haematologica

Lymphoma Diagnosis and TreatmentHistone Deacetylase Inhibitors Research

Cited by 59

Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors: Phase 1 Trial of EZN2208

Norris, R. E., Shusterman, S., Gore, L., Muscal, J. A., Macy, M. E., Fox, E., Berkowitz, N., Buchbinder, A., & Bagatell, R. (2014) · Pediatric Blood & Cancer

Cancer therapeutics and mechanismsPharmaceutical studies and practices

Cited by 38

Safety and Preliminary Efficacy Results of a Phase I First‐in‐Human Study of the Novel Notch‐1 Targeting Antibody Brontictuzumab (OMP‐52M51) Administered Intravenously to Patients with Hematologic Malignancies

Casulo, C., Ruan, J., Dang, N. H., Gore, L., Diefenbach, C., Beaven, A. W., Castro, J. E., Porcu, P., Faoro, L., Dupont, J., et al. (2016) · Blood

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 35